Retrospective analysis of 364 patients undergoing R0 resection after conversion therapy identified postoperative 1-month circulating tumor DNA status, along with KRAS and BRAF V600E mutation status, as key variables in a prognostic model for overall survival. (Zhonghua Yi Xue Za Zhi)
Postoperative ctDNA status predicts survival after conversion therapy for liver metastases
The CRC Digest